Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility Study of Xenaderm Ointment for Partial-Thickness Wounds
NCT00714519Phase 2Withdrawn
- Sponsor
- Healthpoint Biotherapeutics
- Start
- Jul 2008
- Primary completion
- Oct 2008
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
A Phase 2 trial of balsam peru + castor oil + trypsin in wound, sponsored by Healthpoint Biotherapeutics. Planned start Jul 2008; status: withdrawn.
02
Drugs
balsam peru + castor oil + trypsin
03
Conditions
wound
Beyond the preview
Go deeper on NCT00714519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00714519.